Emerging Infectious Diseases

Biography

Yiping Li, Ph.D., Professor of Molecular Virology, Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-sen University (SYSU), Guangzhou, China. Dr. Yiping Li received Ph.D. degree in Biochemistry and Molecular Biology from China Agricultural University, Beijing, China. From 2003 to 2004 and 2006 to 2007, Dr. Li worked as a visiting scholar, project researcher, and postdoctoral researcher in the National Veterinary Institute, Technical University of Denmark (previous Royal Danish Veterinary Institute). In 2005, Dr. Li pursued hepatitis C virus (HCV) research in the Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Canada. To continue HCV research, in February 2008 Dr. Li joined the Copenhagen Hepatitis C Program (CO-HEP), Hvidovre Hospital and Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. After trainings as a postdoc and senior investigator, Dr. Li took a professor position in Zhongshan School of Medicine, SYSU in January 2014

Research Interest

Dr. Yiping Li’s research interests are in the infection and immunity of HCV. To HCV research, Dr. Li has made important contributions, which have included the discoveries on the host RNA insertion-mediated viral resistance to antiviral effect of miR-122 antagonism, the development of novel full-length infectious culture systems for HCV genotypes 1a, 2a and 2b, as well as chimeric culture systems for HCV genotypes 3a, 4a, 5a, and 6a. Dr. Li’s works have led to publications on well-known journals, such as PNAS, Gastroenterology, Hepatology, PLoS Pathogens, Virology. In addition, Dr. Li also worked on animal viruses and Campylobacter. Dr. Li’s research activities have produced 25 publications, 3 U.S. patent applications and 21 conference abstracts; these have included 12 first author publications (served also as corresponding author in 3 publications) and 5 oral presentations out of 13 first author abstracts in outstanding conferences.